Feb 4 (Reuters) - AbbVie forecast 2026 profit above ‌Wall ​Street estimates on Wednesday ‌after posting a fourth-quarter results beat, fueled by strong demand ​for newer immunology drugs Skyrizi and ...

The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...

You know the drill by now. You're sitting in the purgatory of the service center waiting room. Precisely 63 minutes into your wait, the service adviser walks out with a clipboard and calls your name — ...

Even as OpenAI works to harden its Atlas AI browser against cyberattacks, the company admits that prompt injections, a type of attack that manipulates AI agents to follow malicious instructions often ...

Humira is a brand-name drug prescribed to treat rheumatoid arthritis, psoriatic arthritis, and more. It can remain unrefrigerated for up to 14 days, as long as the temperature doesn’t go above 77°F ...

The biosimilar Hyrimoz showed similar flare rates to Humira, but 25% of patients experienced adverse events, mainly injection site reactions. Injection pain, linked to Hyrimoz's citrate content and ...

Like many men his age, William Stern was tired. At 45, the husband, father of three, and founder of Cardiff, a small-business lender, said he felt grateful but “run down” by his very full life.

Kilmeade made the comment Sept. 10, 2025, and it spread widely online on Sept. 13. Kilmeade apologized Sept. 14, calling his remark "extremely callous." In the context of the segment in which it was ...

Amjevita and Imraldi, two biosimilar agents for adalimumab (Humira), were just as effective in treating psoriasis as the original drug for both new users and patients who switched from adalimumab to ...

Medicare may cover epidural steroid injections for pain management when the pain is severe, caused by specific conditions, and lasts over 4 weeks despite other treatment. An epidural steroid injection ...

The Food and Drug Administration approved Gilead's twice-yearly antiviral drug for preventing HIV. The company and some experts say it is a milestone that could help bring the world closer to ending ...

In May 2025, the FDA approved numerous biosimilars as interchangeable with Stelara ® (ustekinumab) and Humira ® (adalimumab), bringing the total number of Stelara ® interchangeables to four, plus an ...